Patents by Inventor Yoshinori Tomida

Yoshinori Tomida has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9610367
    Abstract: There is provided an ICG-loaded polymer nanoparticle that is dynamically stable, prevents the leakage of contained ICG and the resulting discoloration, and has a high molar absorbance coefficient. The particle contains a hydrophilic dye having a sulfonate group and a hydrophobic polymer, and the particle further contains at least one of a lipid having a positively charged region, a nicotinic acid derivative and a thiamine derivative.
    Type: Grant
    Filed: August 23, 2011
    Date of Patent: April 4, 2017
    Assignee: CANON KABUSHIKI KAISHA
    Inventors: Shinzaburo Ito, Masato Minami, Tatsuki Fukui, Kouichi Kato, Fumio Yamauchi, Yoshinori Tomida, Satoshi Yuasa, Tetsuya Yano, Satoshi Ogawa, Kengo Kanazaki, Atsushi Takahashi, Daisuke Sasaguri, Hiroyuki Aoki
  • Patent number: 9132203
    Abstract: There is provided a gelatin-ICG complex that can suppress leakage of ICG included therein. The complex has a gelatin derivative including at least one of a phospholipid covalently bonded to a gelatin or a cholesterol covalently bonded to a gelatin, and indocyanine green.
    Type: Grant
    Filed: April 17, 2014
    Date of Patent: September 15, 2015
    Assignee: Canon Kabushiki Kaisha
    Inventors: Yasuhiko Tabata, Masato Minami, Yoshinori Tomida, Satoshi Yuasa, Tetsuya Yano, Jun-ichiro Jo, Mie Morita
  • Patent number: 9115153
    Abstract: A core of a cyclic structure represented by (—N—(CH2)n—)k is bonded to a dendrimer-type side chain with a specific branched structure at all nitrogen atoms in the core to produce a compound with a specific structure for producing a metal complex that exhibits a T1-reducing effect, and the resulting compound is coordinated to a metal ion that has a T1-reducing effect to obtain a metal complex that exhibits an excellent T1-reducing effect which is useful as an effective component of an MRI contrast agent and an MRI contrast agent using the same.
    Type: Grant
    Filed: May 28, 2014
    Date of Patent: August 25, 2015
    Assignee: Canon Kabushiki Kaisha
    Inventors: Teruyuki Kondo, Hiroshi Tsujita, Zainul Abedin Siddique, Shingo Matsuki, Hiroki Miura, Hidehito Tochio, Tetsuya Matsuda, Michiko Narazaki, Hidetoshi Tsuzuki, Katsuaki Kuge, Yoshinori Tomida, Kimihiro Yoshimura, Tetsuya Yano
  • Publication number: 20140341813
    Abstract: To encapsulate indocyanine green (ICG) at a high concentration in a liposome without causing the agglomeration of ICG so that ICG remains as a monomer in an ICG-containing particle to be used as, for example, a contrast agent for fluorescence imaging or photoacoustic imaging, provided is a method of producing an indocyanine green-containing particle, including the step of mixing indocyanine green, a particle, and a solution containing 1 mM or more and 10 M or less of a chaotropic agent.
    Type: Application
    Filed: April 24, 2014
    Publication date: November 20, 2014
    Applicant: CANON KABUSHIKI KAISHA
    Inventor: Yoshinori Tomida
  • Publication number: 20140275521
    Abstract: A core of a cyclic structure represented by (—N—(CH2)n—)k is bonded to a dendrimer-type side chain with a specific branched structure at all nitrogen atoms in the core to produce a compound with a specific structure for producing a metal complex that exhibits a T1-reducing effect, and the resulting compound is coordinated to a metal ion that has a T1-reducing effect to obtain a metal complex that exhibits an excellent T1-reducing effect which is useful as an effective component of an MRI contrast agent and an MRI contrast agent using the same.
    Type: Application
    Filed: May 28, 2014
    Publication date: September 18, 2014
    Applicant: Canon Kabushiki Kaisha
    Inventors: Teruyuki Kondo, Hiroshi Tsujita, Zainul Abedin Siddique, Shingo Matsuki, Hiroki Miura, Hidehito Tochio, Tetsuya Matsuda, Michiko Narazaki, Hidetoshi Tsuzuki, Katsuaki Kuge, Yoshinori Tomida, Kimihiro Yoshimura, Tetsuya Yano
  • Publication number: 20140227195
    Abstract: There is provided a gelatin-ICG complex that can suppress leakage of ICG included therein. The complex has a gelatin derivative including at least one of a phospholipid covalently bonded to a gelatin or a cholesterol covalently bonded to a gelatin, and indocyanine green.
    Type: Application
    Filed: April 17, 2014
    Publication date: August 14, 2014
    Applicant: CANON KABUSHIKI KAISHA
    Inventors: Yasuhiko Tabata, Masato Minami, Yoshinori Tomida, Satoshi Yuasa, Tetsuya Yano, Jun-ichiro Jo, Mie Morita
  • Patent number: 8772475
    Abstract: A core of a cyclic structure represented by (—N—(CH2)n—)k is bonded to a dendrimer-type side chain with a specific branched structure at all nitrogen atoms in the core to produce a compound with a specific structure for producing a metal complex that exhibits a T1-reducing effect, and the resulting compound is coordinated to a metal ion that has a T1-reducing effect to obtain a metal complex that exhibits an excellent T1-reducing effect which is useful as an effective component of an MRI contrast agent and an MRI contrast agent using the same.
    Type: Grant
    Filed: November 28, 2008
    Date of Patent: July 8, 2014
    Assignee: Canon Kabushiki Kaisha
    Inventors: Teruyuki Kondo, Hiroshi Tsujita, Zainul Abedin Siddique, Shingo Matsuki, Hiroki Miura, Hidehito Tochio, Tetsuya Matsuda, Michiko Narazaki, Hidetoshi Tsuzuki, Katsuaki Kuge, Yoshinori Tomida, Kimihiro Yoshimura, Tetsuya Yano
  • Patent number: 8753608
    Abstract: There is provided a gelatin-ICG complex that can suppress leakage of ICG included therein. The complex has a gelatin derivative including at least one of a phospholipid covalently bonded to a gelatin or a cholesterol covalently bonded to a gelatin, and indocyanine green.
    Type: Grant
    Filed: August 15, 2011
    Date of Patent: June 17, 2014
    Assignee: Canon Kabushiki Kaisha
    Inventors: Yasuhiko Tabata, Masato Minami, Yoshinori Tomida, Satoshi Yuasa, Tetsuya Yano, Jun-ichiro Jo, Mie Morita
  • Publication number: 20130344001
    Abstract: Indocyanine green-containing particles each include a metal oxide particle or a metal particle and an aggregate of indocyanine green. The aggregate of indocyanine green has a relative maximum absorbance at 880 nm or more and 910 nm or less.
    Type: Application
    Filed: June 19, 2013
    Publication date: December 26, 2013
    Inventors: Sachiko Yamauchi, Fumio Yamauchi, Mayuko Kishi, Yoshinori Tomida
  • Publication number: 20130323178
    Abstract: Provided is the following indocyanine green (ICG)-containing particle to be used as, for example, a contrast agent for fluorescent imaging or photoacoustic imaging. The leakage of ICG from the particle in a serum is prevented and hence the particle can stably retain ICG. According to a particle characterized by having an aggregate of indocyanine green and a phospholipid, the leakage of ICG from the particle in a serum or the like is prevented and hence ICG can be stably retained in the particle.
    Type: Application
    Filed: August 6, 2013
    Publication date: December 5, 2013
    Applicant: CANON KABUSHIKI KAISHA
    Inventors: Fumio Yamauchi, Atsushi Takahashi, Kengo Kanazaki, Satoshi Ogawa, Masato Minami, Daisuke Sasaguri, Kouichi Kato, Yoshinori Tomida, Sachiko Yamauchi
  • Publication number: 20130209367
    Abstract: There is provided an ICG-loaded polymer nanoparticle that is dynamically stable, prevents the leakage of contained ICG and the resulting discoloration, and has a high molar absorbance coefficient. The particle contains a hydrophilic dye having a sulfonate group and a hydrophobic polymer, and the particle further contains at least one of a lipid having a positively charged region, a nicotinic acid derivative and a thiamine derivative.
    Type: Application
    Filed: August 23, 2011
    Publication date: August 15, 2013
    Applicant: CANON KABUSHIKI KAISHA
    Inventors: Shinzaburo Ito, Masato Minami, Tatsuki Fukui, Kouichi Kato, Fumio Yamauchi, Yoshinori Tomida, Satoshi Yuasa, Tetsuya Yano, Satoshi Ogawa, Kengo Kanazaki, Atsushi Takahashi, Daisuke Sasaguri, Hiroyuki Aoki
  • Patent number: 8293782
    Abstract: A compound represented by Formula (1) below, where n is 2 or 3; a is an integer of 1 to 4 and b is an integer of 3 and 5 to 10, or a is 5 and b is an integer of 1 to 10; R1 to R8 each independently represent a hydrogen atom or a sulfonate that is any one of sodium sulfonate, potassium sulfonate, ammonium sulfonate, triethylammonium sulfonate, pyridinium sulfonate, lysine sulfonate, and arginine sulfonate; and R9 to R12 each independently represent a substituted or unsubstituted C1-C3 alkyl group.
    Type: Grant
    Filed: January 29, 2010
    Date of Patent: October 23, 2012
    Assignee: Canon Kabushiki Kaisha
    Inventors: Masato Minami, Yoshinori Tomida, Atsushi Takahashi, Kouichi Kato, Fumiko Tomatsu, Sachiko Inoue
  • Publication number: 20120070375
    Abstract: There is provided a gelatin-ICG complex that can suppress leakage of ICG included therein. The complex has a gelatin derivative including at least one of a phospholipid covalently bonded to a gelatin or a cholesterol covalently bonded to a gelatin, and indocyanine green.
    Type: Application
    Filed: August 15, 2011
    Publication date: March 22, 2012
    Applicant: CANON KABUSHIKI KAISHA
    Inventors: Yasuhiko Tabata, Masato Minami, Yoshinori Tomida, Satoshi Yuasa, Tetsuya Yano, Jun-ichiro Jo, Mie Morita
  • Publication number: 20110028713
    Abstract: A core of a cyclic structure represented by (—N—(CH2)n—)k is bonded to a dendrimer-type side chain with a specific branched structure at all nitrogen atoms in the core to produce a compound with a specific structure for producing a metal complex that exhibits a T1-reducing effect, and the resulting compound is coordinated to a metal ion that has a T1-reducing effect to obtain a metal complex that exhibits an excellent T1-reducing effect which is useful as an effective component of an MRI contrast agent and an MRI contrast agent using the same.
    Type: Application
    Filed: November 28, 2008
    Publication date: February 3, 2011
    Applicants: KYOTO UNIVERSITY, CANON KABUSHIKI KAISHA
    Inventors: Teruyuki Kondo, Hiroshi Tsujita, Zainul Abedin Siddique, Shingo Matsuki, Hiroki Miura, Hidehito Tochio, Tetsuya Matsuda, Michiko Narazaki, Hidetoshi Tsuzuki, Katsuaki Kuge, Yoshinori Tomida, Kimihiro Yoshimura, Tetsuya Yano
  • Publication number: 20100197937
    Abstract: A compound represented by Formula (1) below, where n is 2 or 3; a is an integer of 1 to 4 and b is an integer of 3 and 5 to 10, or a is 5 and b is an integer of 1 to 10; R1 to R8 each independently represent a hydrogen atom or a sulfonate that is any one of sodium sulfonate, potassium sulfonate, ammonium sulfonate, triethylammonium sulfonate, pyridinium sulfonate, lysine sulfonate, and arginine sulfonate; and R9 to R12 each independently represent a substituted or unsubstituted C1-C3 alkyl group.
    Type: Application
    Filed: January 29, 2010
    Publication date: August 5, 2010
    Applicant: CANON KABUSHIKI KAISHA
    Inventors: Masato Minami, Yoshinori Tomida, Atsushi Takahashi, Kouichi Kato, Fumiko Tomatsu, Sachiko Inoue
  • Publication number: 20100196278
    Abstract: A molecular probe marked with a color center material is used as a photoacoustic imaging agent to obtain an acoustic signal of practically adequate intensity using weak near-infrared light, which has good in vivo penetration depth but has small excitation energy, and is within the maximum permissible exposure, in photoacoustic tomography (PAT) diagnosis of a living body.
    Type: Application
    Filed: November 14, 2008
    Publication date: August 5, 2010
    Applicant: Canon Kabushiki Kaisha
    Inventor: Yoshinori Tomida
  • Publication number: 20080220550
    Abstract: The object of the present invention is to provide a method of producing an n-type group-13 nitride semiconductor which enables resistance of the n-type group-13 nitride semiconductor to be changed, as well as, a method of producing a laser using the above method to produce a current confinement structure. There is provided a method of producing an n-type group-13 nitride semiconductor, including: preparing an n-type group-13 nitride semiconductor; and irradiating the n-type group-13 nitride semiconductor with light having a wavelength of 350 nm or more to 370 nm or less so as not to change a crystal structure of the n-type group-13 nitride semiconductor before and after the light irradiation, thereby increasing resistance of the n-type group-13 nitride semiconductor.
    Type: Application
    Filed: March 3, 2008
    Publication date: September 11, 2008
    Applicant: CANON KABUSHIKI KAISHA
    Inventor: Yoshinori Tomida
  • Publication number: 20070211319
    Abstract: The invention is to provide a novel display apparatus. The display apparatus includes a display device including a layer constructed by including an alkali halide or an alkali earth halide of which optical characteristics are changed by a laser light irradiation of a first wavelength region equal to or larger than 190 nm but less than 380 nm; a first light source for emitting a laser light of the first wavelength region, in order to write display data in the display device; and a second light source for irradiating the display device in which the display data are written, with a light of a second wavelength region of from 380 to 800 nm.
    Type: Application
    Filed: March 8, 2007
    Publication date: September 13, 2007
    Applicant: CANON KABUSHIKI KAISHA
    Inventor: Yoshinori Tomida
  • Patent number: 7009756
    Abstract: An electrophoretic display device capable of realizing a stable memory characteristic without relying on a circuit-open state is provided. The electrophoretic display device has a cell structure including at least two electrodes, fixing surfaces each associated with one of the at least two electrodes an electrophoretic layer disposed in the cell and comprising an insulating liquid and colored charged particles disposed in the electrophoretic layer, and voltage application device for applying a voltage between the electrodes thereby causing migration of the colored charged particles toward and collective attachment onto one of the fixing surfaces; wherein the fixing surfaces are provided with a charged film having a constant surface charge of a polarity opposite to that of the colored charged particles, regardless of a polarity of electricity supplied to the associated electrodes.
    Type: Grant
    Filed: June 28, 2004
    Date of Patent: March 7, 2006
    Assignee: Canon Kabushiki Kaisha
    Inventors: Etsuro Kishi, Yoshinori Tomida
  • Patent number: 6987502
    Abstract: An electrophoretic display device capable of realizing a stable memory characteristic without relying on a circuit-open state is provided. The electrophoretic display device has a cell structure including at least two electrodes, fixing surfaces each associated with one of said at least two electrodes, an electrophoretic layer disposed in the cell and comprising an insulating liquid and colored charged particles disposed in the electrophoretic layer, and voltage application device for applying a voltage between the electrodes thereby causing migration of the colored charged particles toward and collective attachment onto one of the fixing surfaces; wherein at least one of the timing surfaces and the colored charged particles is provides with an adhesive layer allowing repetitive attachment thereto and separation therefrom of the colored charged particles; or the fixing surfaces are provided with a charged film having a constant surface charge of a polarity opposite to that of the colored charged particles.
    Type: Grant
    Filed: January 7, 2000
    Date of Patent: January 17, 2006
    Assignee: Canon Kabushiki Kaisha
    Inventors: Etsurō Kishi, Yoshinori Tomida